When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MKGAY - Pfizer's Bavencio + Inlyta OK'd in Europe for first-line kidney cancer
Merck KGaA ADR
Pfizer (PFE+1.3%) and alliance partner EMD Serono (OTCPK:MKGAY) announce European Commission approval of Bavencio (avelumab), combined with Inlyta (axitinib), for the first-line treatment of adult patients with advanced renal cell carcinoma.
More news on: Pfizer Inc., Merck KGaA ADR, Healthcare stocks news,